FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083428405> ?p ?o ?g. }

• W2083428405 endingPage "6592" @default.
• W2083428405 startingPage "6586" @default.
• W2083428405 abstract "The inhibition of the mammalian soluble epoxide hydrolase (sEH) is a promising new therapy in the treatment of hypertention and inflammation. The problems of limited water solubility and high melting points commonly displayed by the active 1,3-disubstituted ureas prevent the further development of potent urea-based sEH inhibitors. Therefore, a new class of potent inhibitors of sEH were designed and synthesized by the introduction of a polar constrained piperazino group in the right side of adasmantyl urea to increase the water solubility. A facile and general synthesis was established to prepare a series of 1-adamantan-1-yl-3-(2-piperazin-2-yl-ethyl)-ureas (1a-d) with various 5-substitutions on the 2-piperazino ring, which will advance the SAR study by the efficient making of structurally diverse analogs. The effect of the 5-substitution on the activity and the water solubility was examined. The best potency was exhibited by the 5-benzyl-substituted-piperazine-containing urea with an IC50 value of 1.37 microM against human sEH and good water solubility (S=7.46 mg/mL) and low melting point, in which the 5-substituted piperazine serves as a favorable secondary pharmacophore and a water-solubility enhancing group. Our present work provides a promising new template for the design of orally available therapeutic agents for the disorders that can be addressed by changing the in vivo concentration of the chemical mediators that contain an epoxide." @default.
• W2083428405 created "2016-06-24" @default.
• W2083428405 creator A5013909385 @default.
• W2083428405 creator A5019174025 @default.
• W2083428405 creator A5023865749 @default.
• W2083428405 creator A5026538320 @default.
• W2083428405 creator A5034903834 @default.
• W2083428405 date "2006-10-01" @default.
• W2083428405 modified "2023-10-18" @default.
• W2083428405 title "The 5-substituted piperazine as a novel secondary pharmacophore greatly improving the physical properties of urea-based inhibitors of soluble epoxide hydrolase" @default.
• W2083428405 cites W1619653867 @default.
• W2083428405 cites W1965472666 @default.
• W2083428405 cites W1975219953 @default.
• W2083428405 cites W1976261167 @default.
• W2083428405 cites W1977977619 @default.
• W2083428405 cites W1980978175 @default.
• W2083428405 cites W1987124995 @default.
• W2083428405 cites W1989552333 @default.
• W2083428405 cites W1993788673 @default.
• W2083428405 cites W2003402669 @default.
• W2083428405 cites W2011144703 @default.
• W2083428405 cites W2011846059 @default.
• W2083428405 cites W2016949419 @default.
• W2083428405 cites W2061837477 @default.
• W2083428405 cites W2062531547 @default.
• W2083428405 cites W2065801700 @default.
• W2083428405 cites W2066093944 @default.
• W2083428405 cites W2071253818 @default.
• W2083428405 cites W2098905461 @default.
• W2083428405 cites W2103166794 @default.
• W2083428405 cites W2111204258 @default.
• W2083428405 cites W2129077714 @default.
• W2083428405 cites W2132899427 @default.
• W2083428405 cites W2146083192 @default.
• W2083428405 cites W2182635476 @default.
• W2083428405 cites W2329501096 @default.
• W2083428405 doi "https://doi.org/10.1016/j.bmc.2006.06.005" @default.
• W2083428405 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2040075" @default.
• W2083428405 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16784862" @default.
• W2083428405 hasPublicationYear "2006" @default.
• W2083428405 type Work @default.
• W2083428405 sameAs 2083428405 @default.
• W2083428405 citedByCount "29" @default.
• W2083428405 countsByYear W20834284052012 @default.
• W2083428405 countsByYear W20834284052013 @default.
• W2083428405 countsByYear W20834284052014 @default.
• W2083428405 countsByYear W20834284052016 @default.
• W2083428405 countsByYear W20834284052017 @default.
• W2083428405 countsByYear W20834284052018 @default.
• W2083428405 countsByYear W20834284052019 @default.
• W2083428405 countsByYear W20834284052020 @default.
• W2083428405 countsByYear W20834284052022 @default.
• W2083428405 countsByYear W20834284052023 @default.
• W2083428405 crossrefType "journal-article" @default.
• W2083428405 hasAuthorship W2083428405A5013909385 @default.
• W2083428405 hasAuthorship W2083428405A5019174025 @default.
• W2083428405 hasAuthorship W2083428405A5023865749 @default.
• W2083428405 hasAuthorship W2083428405A5026538320 @default.
• W2083428405 hasAuthorship W2083428405A5034903834 @default.
• W2083428405 hasBestOaLocation W20834284052 @default.
• W2083428405 hasConcept C13530604 @default.
• W2083428405 hasConcept C155574463 @default.
• W2083428405 hasConcept C161790260 @default.
• W2083428405 hasConcept C178790620 @default.
• W2083428405 hasConcept C181199279 @default.
• W2083428405 hasConcept C185592680 @default.
• W2083428405 hasConcept C18605011 @default.
• W2083428405 hasConcept C21951064 @default.
• W2083428405 hasConcept C2776201271 @default.
• W2083428405 hasConcept C2776920199 @default.
• W2083428405 hasConcept C2780365088 @default.
• W2083428405 hasConcept C56173144 @default.
• W2083428405 hasConcept C71240020 @default.
• W2083428405 hasConceptScore W2083428405C13530604 @default.
• W2083428405 hasConceptScore W2083428405C155574463 @default.
• W2083428405 hasConceptScore W2083428405C161790260 @default.
• W2083428405 hasConceptScore W2083428405C178790620 @default.
• W2083428405 hasConceptScore W2083428405C181199279 @default.
• W2083428405 hasConceptScore W2083428405C185592680 @default.
• W2083428405 hasConceptScore W2083428405C18605011 @default.
• W2083428405 hasConceptScore W2083428405C21951064 @default.
• W2083428405 hasConceptScore W2083428405C2776201271 @default.
• W2083428405 hasConceptScore W2083428405C2776920199 @default.
• W2083428405 hasConceptScore W2083428405C2780365088 @default.
• W2083428405 hasConceptScore W2083428405C56173144 @default.
• W2083428405 hasConceptScore W2083428405C71240020 @default.
• W2083428405 hasIssue "19" @default.
• W2083428405 hasLocation W20834284051 @default.
• W2083428405 hasLocation W20834284052 @default.
• W2083428405 hasLocation W20834284053 @default.
• W2083428405 hasLocation W20834284054 @default.
• W2083428405 hasOpenAccess W2083428405 @default.
• W2083428405 hasPrimaryLocation W20834284051 @default.
• W2083428405 hasRelatedWork W1191097708 @default.
• W2083428405 hasRelatedWork W1983225776 @default.
• W2083428405 hasRelatedWork W1986410527 @default.
• W2083428405 hasRelatedWork W2018119061 @default.
• W2083428405 hasRelatedWork W2083428405 @default.

• next